StockData
NovoCure Ltd logo

NovoCure Ltd (NVCR) bonds

NVCRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/3031% below fair value
$11.14−0.16 (-1.42%)

Close on Nov 17, 2026Market cap $1.30BP/E –Yield –

Debt

Borrowings on the balance sheet, Sep 30, 2026

NovoCure reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

As tagged in NovoCure's 10-Q for the period ended Sep 30, 2026

NovoCure's filings do not break debt down by note

The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySizeDrawn
2024 Credit Facility$400.00M$195.05M
2024 Credit Facility Tranche A$200.00M$196.34M
Revolving credit facility$200.00M$195.05M

See a number that looks wrong?